JEFFREY MANESE: Open Payments
NPI 1619023769 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 16 payments from 4 companies in 2025. Trend: 2023 $422 · 2024 $609 · 2025 $568
Food & beverage: $542Speaker / faculty: $26
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $325 |
| MDD US Operations, LLC | 7 | $176 |
| Neurocrine BioSciences, Inc. | 1 | $40 |
| ABBVIE INC. | 1 | $27 |
Products named: General - DBS, Vercise, INGREZZA, VYALEV.
Industry payments across CA — which companies pay providers there.
